Alpha-bungarotoxin binding and central nervous system nicotinic acetylcholine receptors

Irreversible autonomic actions by lophotoxin suggest utility as a probe for both C6 and C10 nicotinic receptors

The marine natural product lophotoxin has produced a non-reversible antagonism of parasympathetic and sympathetic functions that are known to be mediated by C6 sub-type nicotinic receptors. Transmission through anuran paravertebral ganglia was eliminated in 20-40 min by 10-30-min treatments with 16-32 microM lophotoxin, in a time course resembling the onset of block of C10 sub-type nicotinic receptors at the neuromuscular junction and in cultured BC3H-1 cells. The action persisted through 16 h of washout. Nerve conduction was unaffected. Somewhat longer treatments (80 min) of in vitro ileal sections resulted in loss of sensitivity to nicotine, but not to acetylcholine, for at least 5 h. These data indicate that lophotoxin can serve as a more universal nicotinic receptor probe than the alpha-neurotoxins, which may bind to both C6 and C10 sub-types, but block only the C10.

Purification and characterization of the alpha-bungarotoxin binding protein from rat brain

The alpha-bungarotoxin (BGT) binding protein from rat brain has been purified and its polypeptide chain composition has been examined by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Polypeptide chains with Mrs of 55,000, 53,500 and 49,000 have been identified as constituents of the protein. The affinity ligand [3H]maleimidobenzyl trimethylammonium bromide ([3H]MBTA), used to identify the ligand binding site on neuromuscular junction acetylcholine receptors (NMJ AChRs), binds to the 55,000 dalton polypeptide chain. Using a technique where ligands are bound to the protein while the protein is immobilized on alpha-cobratoxin-Sepharose 4B, it was established that the brain BGT binding protein, like NMJ AChRs, possesses two binding sites for BGT. These experiments reinforce previous evidence that the brain BGT binding protein is closely related but not identical to NMJ AChRs.

Brain and muscle nicotinic acetylcholine receptors are different but homologous proteins

An alpha-bungarotoxin-binding protein was purified from chick optic lobe and brain by an improved method. Previous and present observations justify its designation as a brain nicotinic acetylcholine receptor (AcChoR). It contains subunits whose apparent molecular weights are somewhat larger than those of subunits of peripheral AcChoRs. The size of the optic lobe AcChoR complex is greater than that of the peripheral receptor when estimated from its sedimentation behavior. Brain AcChoR subunits can be specifically precipitated by a monoclonal antibody directed against chick muscle AcChoR. Amino-terminal amino acid sequence analysis was performed on AcChoR preparations and isolated subunits from the optic lobe and from the rest of the chick brain. The sequences obtained demonstrate that, at least for the lowest molecular weight component, the AcChoRs from different brain areas are identical and they are highly homologous to muscle AcChoR. It is concluded that the brain alpha-bungarotoxin-binding protein is indeed a nicotinic AcChoR and is encoded by a set of genes that is different from, but strongly related to, that for the muscle AcChoR.

Activity regulates the levels of acetylcholine receptor alpha-subunit mRNA in cultured chicken myotubes

In vitro blocking the spontaneous activity of primary cultures of chicken embryo myotubes with tetrodotoxin increases approximately equal to 2-fold their content in surface acetylcholine receptor. To investigate this effect at the level of gene expression, chicken genomic DNA sequences coding for the acetylcholine receptor alpha subunit were isolated and characterized. They were shown to belong to a single-copy, polymorphic gene with at least two alleles in the chicken strain utilized. Probes derived from these genomic clones were used to quantitate levels of alpha-subunit mRNA. In culture, a 2-day exposure to tetrodotoxin increased these mRNA levels up to 13-fold, a value similar to that observed after denervation of chick leg muscle (approximately equal to 17-fold). Actin mRNA levels varied little in any of these experiments. These results support the notion that membrane electrical activity affects acetylcholine receptor expression by regulating the accumulation of the corresponding mRNAs.

Comparative analysis of nicotine-like receptor-ligand interactions in rodent brain homogenate

The effects of different variables such as incubation time, temperature, tissue protein content, and pH on the interactions of various labelled nicotinic ligands with nicotine-like binding sites in vitro were studied in rodent brain preparations. The ligands tested were alpha-[3H]bungarotoxin (alpha-[3H]BTX), [3H]tubocurarine ([3H]TC), and [3H]nicotine ([3H]NIC). The regional distribution of the labelled nicotinic ligand binding was also studied and affinity constants and maximal binding (Bmax) values for the equilibrium [3H]NIC binding are given. Association kinetics for [3H]NIC and [3H]TC binding to brain homogenate were similar, with maximal binding within 5-10 min of incubation, followed by a continuous decrease. In contrast, the binding of alpha-[3H]BTX to brain homogenate was much slower, reaching equilibrium after 30-60 min of incubation. Scatchard analysis of equilibrium binding data for [3H]NIC in the hippocampus indicated two binding sites: a high-affinity site (Bmax, 60 pmol/g protein; KD, 6 nM) and a low-affinity site (Bmax, 230 pmol/g protein; KD, 125 nM). The data for the high-affinity [3H]NIC binding site are very similar to previously found data for the high-affinity binding site of [3H]TC and the binding site of alpha-[3H]BTX. Each ligand showed regional differences in binding, and the binding pattern also differed between the ligands.

Isolation of a polypeptide from the venom of Bungarus multicinctus that binds to ganglia and blocks the ganglionic transmission in mammals

A 15,000 dalton polypeptide purified from Bungarus multicinctus venom (which normally copurifies with alpha-bungarotoxin) was characterized biochemically and its biological effects were studied. This polypeptide, P15, had an aminoacid composition and molecular weight different from those of both alpha- and beta-bungarotoxin. It inhibited the ganglionic transmission in the guinea-pig hypogastric nerve-vas deferens preparation and did not block, even at very high concentrations, the neuromuscular transmission in the rat phrenic nerve-diaphragm preparation. In the same preparations alpha-bungarotoxin was unable to block the response at the ganglionic synapse while it was fully active in blocking the neuromuscular transmission. However, a pretreatment of the vas deferens preparation with alpha-bungarotoxin prevented the inhibitory effect of P15. 125I-Labeled P15 showed a specific and saturable binding to rat superior cervical ganglia homogenate and to a Torpedo postsynaptic membrane fraction. The binding of P15 to ganglia was inhibited by curare. The binding was Ca2+ dependent. The density of binding sites was of 300 fmol/mg of protein in the ganglion and 500 fmol/mg of protein in Torpedo membranes. The amount of P15-binding sites in ganglia was not modified by denervation, indicating that P15 binds to postsynaptic receptors. The binding of 125I-labeled P15, both in ganglia and Torpedo membranes, was inhibited by alpha-bungarotoxin. P15 had a Ca2+-dependent phospholipase A2 activity. Lowering Ca2+ concentration in incubation media affected the phospholipase A2 activity more than binding properties and inhibition of phospholipase activity with p-bromophenacyl bromide did not affect the activity of P15 on vas deferens preparation, suggesting that the phospholipase activity is not necessary for the activity of P15 on nicotinic receptors. Our results suggest that P15 toxin may be a specific and valuable probe for studying the ganglionic nicotinic receptor.

Binding characteristics of the bungarotoxin fraction II-S1 to rat brain membranes

Bungarotoxin fraction II-S1 (designated BGT II-S1), isolated from the venom of Bungarus multicinctus, appears to affect nicotinic transmission in rat sympathetic ganglia through its phospholipase activity. On the other hand, the present investigation suggests that other modes of interaction of this toxin with nervous tissue may also exist as, in a rat brain membrane preparation, binding of this toxin to a specific binding site can be demonstrated. In a buffer containing calcium, binding of [125I]BGT II-S1 saturated with a Bmax of approximately 16 fmol/mg protein and a Kd of 5 nM. This site did not appear to be directly linked to the nicotinic acetylcholine recognition site as the binding was not displaced by nicotinic agents; however, alpha-bungarotoxin, which interacts with a nicotinic-like site in neural tissue, did affect the binding and, conversely, BGT II-S1 inhibited the binding of [125I]alpha-bungarotoxin.

Enhancement by estrogen treatment of -bungarotoxin binding in fetal mouse amygdala cells reaggregated in vitro

Dissociated amygdala cells from 17-day-old mouse fetuses were cultivated in a flask for 7 days to form aggregates. In the aggregates there developed typical synaptic structures and [125I]alpha-bungarotoxin binding capacity. An addition of estradiol (100 ng/ml) in the culture medium caused a significant increase in the toxin binding capacity. From these results it is concluded that estradiol enhances alpha-bungarotoxin binding capacity in the amygdala by exerting direct effects on the developing amygdala cells.

Genetically determined differences in acute responses to diisopropylfluorophosphate

The acute effects of diisopropylfluorophosphate (DFP) were assessed in DBA/2Ibg, C57BL/6Ibg and C3H/2Ibg mice. The DFP was administered by intraperitoneal injection in saline. Brain acetylcholinesterase (AChE) activity was maximally inhibited within 5 min after injection. All mice showed signs of organophosphate intoxication including salivation, lacrimation, diarrhea, respiratory distress, tremor and, at high doses, seizures. The C57BL mice were most susceptible to these effects of DFP. The LD50 values for DFP were 8.0, 7.6, and 6.8 mg/kg for male DBA, C3H, and C57BL mice, respectively. The LD50 values for females were nearly the same. Body temperature and brain AChE activity decreased in a dose-dependent manner following injections of DFP of 3.17, 4.22, 5.28, and 6.33 mg/kg. Maximum temperature depression occurred 2 hours after DFP administration; by 24 hours temperatures had returned to normal except for C57BL mice treated with the highest dose of DFP. The C57BL strain was most susceptible to the DFP-induced hypothermia, the C3H strain was the most resistant, and the DBA strain was intermediate. Maximum temperature depression and residual AChE activity, as measured 24 hours after injection, were linearly related. These strain differences do not seem to be explained easily by a differential inhibition of AChE activity.

Localization of alpha-bungarotoxin binding sites in the ciliary ganglion of the embryonic chick: an autoradiographic study at the light and electron microscopic level

Binding sites for [125I]alpha-bungarotoxin were localized in the chick ciliary ganglion by light and electron microscopic autoradiography. Groups of four ganglia were incubated for 4 h with 20 nM [125I]alpha-bungarotoxin alone or with radioactive alpha-bungarotoxin plus either 1 microM unlabeled alpha-bungarotoxin or 100 microM d-tubocurarine. Specific binding to various morphological regions was determined by subtracting the densities of autoradiographic grains in the presence of competing nonradioactive ligands from the densities in the absence of those ligands. Most of the specific binding in the ganglion (91%) was associated with neurons. Seventy-four per cent was found within 1.2 micron of neuronal plasma membranes and 17% was found overlying neuronal cell bodies. Analysis of the specific binding associated with neurons, but not with the neuronal plasma membranes, revealed that lysosomes and multivesicular bodies were 9- and 32-fold more heavily labeled than other cellular organelles. The grain density over choroid cell bodies was significantly higher than that over ciliary neurons. Most (greater than 75%) of the autoradiographic grains within 0.25 micron of neuronal plasma membranes were found in "complex" contact regions of the membranes, which are characterized by extensive membrane evaginations. However, after correcting for the amount of plasma membrane present in the various regions of the membrane studied, alpha-bungarotoxin binding was found to be uniform. Few (less than 10%) of the specialized membranes between pre- and postsynaptic neurons were found in these "complex" contact regions suggesting that the bulk of alpha-bungarotoxin binding to neuronal membranes is located at some distance from the sites of transmitter release. The density of alpha-bungarotoxin binding sites in the neuronal plasma membrane was low (approximately 100-200 sites/micron 2 of neuronal membrane) compared to published values of the density of binding sites at the neuromuscular junction. Since alpha-bungarotoxin does not bind preferentially to specialized synaptic membranes, it seems unlikely that the binding sites for this toxin are the neuronal nicotinic receptors.

Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine

Saline, 8.0 mg/kg/hr nicotine, or 1.0 mg/kg/hr oxotremorine was continuously infused into the jugular veins of DBA female mice. After 10 days of treatment, respiratory rate, Rotarod performance, Y-maze crossings, Y-maze rears, heart rate, and body temperature were measured after challenge with 2.0 mg/kg nicotine or saline or 0.2 mg/kg oxotremorine. Nicotine-infused mice were tolerant to the effects of nicotine for all six tests and oxtremorine-infused mice were tolerant to the effects of oxotremorine for all six tests and to the effects of nicotine on heart rate and body temperature. Oxotremorine infusion reduced the Bmax for [3H]-L-QNB binding, but had no effect on Bmax for either [3H]-DL-nicotine or [125I]-alpha-BTX binding. Conversely nicotine infusion did not alter the Bmax for [3H]-L-QNB binding, but increased the Bmax for both [3H]-DL-nicotine and [125I]-alpha-BTX binding. These results indicate that tolerance developed to the effects of two cholinergic agents, nicotine and oxotremorine, and that some cross-tolerance to the effects of nicotine occurred in oxotremorine-treated mice. Treatment with oxotremorine caused down-regulation of muscarinic receptors, while treatment with nicotine caused up-regulation of nicotinic receptors. Although some cross-tolerance to the effects of nicotine occurred in oxotremorine-treated mice, this did not appear to result from changes in nicotinic receptors.

Inhibition of nicotinic receptor mediated ion fluxes in rat sympathetic ganglia by BGT II-S1 a potent phospholipase

The mechanism of action of the bungarotoxin fraction II-S1 (BGT II-S1), which copurifies with alpha-bungarotoxin (alpha-BGT) and inhibits nicotinic transmission, has been further characterized. BGT II-S1 (1 microM) inhibited the carbachol (100 microM) or nicotine (50 microM) stimulated uptake of [3H]agmatine into rat sympathetic ganglia by 73% and 52%, respectively. These responses were inhibited 90% by D-tubocurarine (100 microM), but unaffected by alpha-BGT (1 microM) or atropine (10 microM), suggesting that BGT II-S1 affects nicotinic function at a postsynaptic site. Binding of physiologically active [125I]BGT II-S1 could be demonstrated to intact sympathetic ganglia; however, the binding could not be displaced by nicotinic agents, suggesting that BGT II-S1 is not interacting at the receptor. Because some neurotoxins produce their effect at the synapse through a phospholytic action, the phospholipase activity of BGT II-S1 was determined. The results demonstrate that BGT II-S1 is a very potent calcium dependent phospholipase. In addition, conditions which abolished the toxin's phospholytic activity prevented its effects on nicotinic transmission and on nicotinic receptor mediated ion fluxes. These include irreversible inhibition of enzymic activity by treatment of BGT II-S1 with p-bromophenacylbromide, as well as reversible inhibition of the phospholipase by substitution of Ba2+ or Sr2+ ions for Ca2+ ions in the physiological medium. Thus, in rat sympathetic ganglia, BGT II-S1 blocks the nicotinic receptor mediated movement of ions across the membrane. This is probably not due to a direct interaction at the nicotinic acetylcholine recognition site; rather, it may be an ion channel associated effect which is mediated by alterations in the phospholipid environment of the receptor complex or of the membrane. Although BGT II-S1 also has presynaptic actions, in a cultured system of postsynaptic cells, it could prove a useful tool to study the role of phospholipids in neuronal nicotinic receptor regulation.

Autoradiographic localization of [3H]nicotine binding sites in the rat brain

In vitro autoradiography was used to visualize [3H]nicotine binding sites in the rat brain. Labeling was densest in the interpeduncular nucleus and medial habenula but was also detected in thalamic nuclei, areas related to sensory function, the cerebral cortex, and molecular layer of the dentate gyrus. Specific binding was sparse in the hypothalamus and caudate-putamen, and not detected in Ammon's horn of the hippocampus or in the periaqueductal grey matter. These findings may relate to the distribution of nicotine's cerebral loci of action.

Binding of N-[propionyl-3H]propionylated alpha-bungarotoxin and L-[benzilic-4,4'-3H] quinuclidinyl benzilate to CNS extracts of the cockroach Periplaneta americana

The nerve cord of the cockroach (Periplaneta americana) contains distinct saturable components of specific binding for the ligands N-[propionyl-3H]propionylated alpha-bungarotoxin and L-[benzilic-4,4'-3H]quinuclidinyl benzilate. N-[Propionyl-3H]propionylated alpha-bungarotoxin bound reversibly to homogenates with a Kd of 4.8 nM and Bmax of 910 fmol mg-1. The association rate constant (1.9 X 10(5) M-1 s-1) and dissociation rate constant (1.2 X 10(-4) s-1) yielded a Kd of 0.6 nM. Nicotinic ligands were found to displace toxin binding most effectively. The binding sites characterized in this way showed many similarities with the properties of the vertebrate neuronal alpha-bungarotoxin binding site. For a range of cholinergic ligands, inhibition constants calculated from toxin binding studies closely corresponded to their effectiveness in blocking the depolarizing response to acetylcholine recorded by electrophysiological methods from an identified cockroach motoneurone. The N-[propionyl-3H]propionylated alpha-bungarotoxin binding component therefore appears to be a constituent of a functional CNS acetylcholine receptor. Binding of L-[benzilic-4,4'-3H]quinuclidinyl benzilate was reversible with a Kd of 8 nM and Bmax of 138 fmol mg-1, determined from equilibrium binding experiments. The Kd calculated from the association rate constant (2.4 X 10(5) M-1 s-1) and dissociation rate constant (1.3 X 10(-4) s-1) was 1.9 nM. Muscarinic ligands were the most potent inhibitors of quinuclidinyl benzilate binding. The characteristics of this binding site resembled those of vertebrate CNS muscarinic cholinergic receptors. In contrast with vertebrate CNS, the nerve cord of Periplaneta americana contains more (approximately X 7) alpha-bungarotoxin binding sites than quinuclidinyl benzilate binding sites.

Autoradiographic distribution of nicotine receptors in rat brain

The autoradiographic visualisation of 90%-specific tritiated nicotine binding to slide-mounted sections of rat brain is reported. Tritiated nicotine bound with high affinity (nanomolar Kd) and was selectively displaced by nicotinic agonists (e.g. L-nicotine approximately ACh greater than D-nicotine). The strikingly discrete distribution pattern obtained deviates from that of alpha-bungarotoxin, and suggests several possible roles for nicotinic transmission in the brain.

Concanavalin A inhibits nicotinic acetylcholine receptor function in cultured chick ciliary ganglion neurons

The effects of various lectins and toxins on neuronal nicotinic acetylcholine receptor function have been studied in primary cultures of chick ciliary ganglion neurons. Neuronal response to acetylcholine receptor activation was measured by a cation flux method at 4 degrees C in a high potassium-low sodium medium designed to stabilize membrane potential near zero, with acetylcholine as the agonist and cesium-137 as the tracer ion. Exposure to 1 mM acetylcholine for 30 s produced a 5-10-fold stimulation of cesium-137 influx. Acetylcholine-stimulated influx was inhibited more than 95% by 10 microM D-tubocurarine, but was insensitive to both 1 microM tetrodotoxin and 1 microM alpha-bungarotoxin. Concanavalin A (50 micrograms/ml) inhibited agonist-induced ion flux by 80% at 4 degrees C. Succinyl-concanavalin A was ineffective at concentrations up to 250 micrograms/ml, and could not protect against the concanavalin A inhibition. However, inhibition by concanavalin A was eliminated by prior incubation of the lectin with 0.2 M alpha-methyl-D-mannoside and subsequent co-incubation with the sugar. Wheat germ agglutinin, lentil lectin, cholera toxin and tetanus toxin were without effect at either 4 degrees C or 37 degrees C. These results suggest a specific interaction between concanavalin A and neuronal nicotinic acetylcholine receptors.

Characterization of a snake venom neurotoxin which blocks nicotinic transmission in the avian ciliary ganglion

Bungarus multicinctus venom was fractionated by ion exchange chromatography and the various fractions were assayed for their ability to block synaptic transmission through the chick ciliary ganglion. alpha-Bungarotoxin purified from this venom failed to block transmission at 50 micrograms/ml. A second neurotoxin, which we designate Toxin F, blocked transmission at 1-3 micrograms/ml and also blocked ganglionic depolarizations induced by carbachol. Toxin F was clearly distinguishable from alpha-bungarotoxin on the basis of molecular weight (estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and isoelectric point. Binding assays revealed that 125I-labeled toxin F bound to two sites in the ciliary ganglion: one site that was shared by alpha-bungarotoxin and toxin F and another site that was recognized solely by toxin F. Carbachol and d-tubocurarine displaced only that [125I]toxin F bound to the shared site and had no effect on [125I]toxin F bound to the site recognized by toxin F alone. The results suggest that toxin F blocks synaptic transmission in the chick ciliary ganglion by a postsynaptic mechanism. Further study is required to determine whether this effect of toxin F is mediated through a direct interaction with ganglionic nicotinic receptors.

Two types of glomus cell in the rat carotid body as revealed by alpha-bungarotoxin binding

Horseradish peroxidase (HRP)-conjugated alpha-bungarotoxin (alpha Bgt) was used to localize alpha Bgt-acetylcholine receptor sites in the rat carotid body. Two types of glomus cell were differentiated on the basis of the staining of their plasma membranes by the conjugate: type A, devoid of staining or only partly stained; and type B, exhibiting staining over the entire cell surface. The parts of type A glomus and supporting cells stained were always in direct apposition to type B glomus cells. It is concluded that type B glomus cells are possibly the only cell types exhibiting specific binding sites of alpha Bgt. Other morphological characteristics and quantitative studies indicated that the type A and type B glomus cells presented in this study were equivalent to those described in the rat carotid body by other investigators (McDonald & Mitchell, 1975). alpha Bgt-HRP staining facilitated the observation of the distribution pattern of glomus cells in the parenchyma: type A glomus cells were arranged in groups and often showed polarity toward neural elements and sinusoidal capillaries; and clusters of type B glomus cells were frequently situated in a demilune -like fashion over groups of type A glomus cells. Because of differences in morphology, synaptology, alpha Bgt-binding affinity, and polarity toward the blood vessels, we propose that type A and type B glomus cells in the rat carotid body represent functionally distinct cell types.

Properties of monoclonal antibodies to nicotinic acetylcholine receptor from chick muscle

Four stable, hybrid-cell lines secreting monoclonal antibodies to distinct determinants on the nicotinic acetylcholine receptor from chick muscle have been established. These were characterised by the following criteria: immunoglobulin isotype, ability to produce experimental autoimmune myasthenia gravis in mice and reactivity towards homologous and heterologous acetylcholine receptor proteins. Two monoclonal antibodies were found to inhibit the reaction of alpha-bungarotoxin with homologous acetylcholine receptor; in addition one of these, on binding to receptor-toxin, induced a rapid dissociation of the complex (t1/2 = 0.5 h at 23 degrees C). Three of the antibody preparations recognised epitopes on this receptor from muscle of other species and two of these caused experimental autoimmune myasthenia gravis in BALB/c mice following passive transfer. The latter two recognised to significant extents the alpha-bungarotoxin binding component purified from chick optic lobe and brain cortex. Sedimentation analysis demonstrated that two of the monoclonal antibodies form a distinct size (s20, w = 12S) of complex with the receptor of chick muscle which most probably corresponds to a 1:1 attachment of antibody and receptor; this may involve cross-linking of two determinants within the same oligomer. A similar observation was made with the alpha-bungarotoxin binding component from optic lobe using one of the cross-reacting antibodies. Another monoclonal antibody was found to be capable of forming much heavier complexes with the receptor from chick muscle, these are thought to involve inter-molecular cross-linking of oligomers. The observed properties of these antibodies are discussed in relation to their myasthenogenicity and with reference to the extent of structural similarities between the peripheral nicotinic acetylcholine receptor and the alpha-bungarotoxin binding protein from brain.

Effect of alpha-bungarotoxin and etorphine on acetylcholine-evoked release of endogenous and radiolabeled catecholamines from primary culture of adrenal chromaffin cells

Cell cultures of adrenal medulla have become an important research tool to study basic processes that regulate catecholamine storage, release and synthesis. Release has been studied either by labeling with [3H]norepinephrine and measuring release of radioactivity or by measuring the endogenous catecholamines released with HPLC. Acetylcholine (5 X 10(-6)-10(-4) M) appears to release preferentially norepinephrine, although the cells store more epinephrine than norepinephrine. Etorphine and alpha-bungarotoxin antagonize the release of catecholamines elicited by acetylcholine. This inhibitory action appears to be greater when the measurement of endogenous catecholamines rather than radioactive norepinephrine is used to monitor the action of acetylcholine. The data suggest that the measurement of endogenous catecholamines by HPLC is preferable to the [3H]NE loading and release technique, especially when analyzing the effects of low concentrations of drugs that are thought to affect nicotinic receptor function.

Specific binding of alpha-bungarotoxin to synaptic membranes in rat sympathetic ganglion: computer best-fit analysis of electron microscope radioautographs

In the rat superior cervical sympathetic ganglion (SCG), alpha-bungarotoxin (alpha BT) demonstrates binding that is saturable and inhibited by nicotinic ligands. However, alpha BT does not inhibit the physiological response of ganglionic neurons to preganglionic stimulation or to exogenously applied acetylcholine. Thus the specificity of alpha BT for ganglionic nicotinic cholinergic receptors has been questioned. The present study provides a morphological localization of the binding sites of 125I-labelled alpha BT in the rat SCG using the method of Blackett and Parry on electron microscopic radioautographs. The distribution of grains resulting from specific binding was calculated by subtracting the nonspecific distribution (alpha BT in the presence of D-tubocurarine, a known nicotinic ligand) from the total grain distribution (alpha BT alone). A hypothetical grain distribution was obtained based on the geometrical properties of the tissue sections. A computer minimizing routine was employed to adjust the relative weights of each of the potential sources of hypothetical grains until a 'best-fit' with the real grain distributions occurred. The nonspecific binding of alpha BT was uniform across all tissue components, with the exception of a significant concentration on the membrane of the ganglion cell body. By contrast, the specific binding of alpha BT was highly localized to synaptic membranes, and to a lesser extent, to dendritic membranes.

Kappa-bungarotoxin: an intracellular study demonstrating blockade of neuronal nicotinic receptors by a snake neurotoxin

Pressure injection of carbachol elicited dose-dependent depolarizations of the principal ganglionic neurons in embryonic chick ciliary ganglia. These depolarizations were associated with a marked decrease in input resistance. Carbachol-induced depolarizations were completely and reversibly antagonized by the snake neurotoxin Kappa-bungarotoxin but not by alpha-bungarotoxin. Kappa-bungarotoxin, therefore, appears to be a specific probe for the postsynaptic neuronal nicotinic receptor in the avian ciliary ganglion.

Kappa-bungarotoxin: a probe for the neuronal nicotinic receptor in the avian ciliary ganglion

The interaction of snake alpha-neurotoxins with neuronal membranes has been examined in the chick ciliary ganglion. Some, but not all, alpha-neurotoxins block nicotinic transmission in this ganglion. alpha-Bungarotoxin (ABgT), the major alpha-neurotoxin in the venom of Bungarus multicinctus, does not block transmission at high concentrations (1.2 microM) although it binds (Kd = 1 nM) to a pharmacologically nicotinic site in the ganglion. A toxin (kappa-bungarotoxin, KBgT) has been purified from the venom of Bungarus multicinctus. KBgT has a molecular weight of 6500 daltons and a pI of 9.1. KBgT is a potent inhibitor of nicotinic transmission in the ciliary ganglion, producing a reversible (overal several hours) blockade at 75 nM. Pre-exposure of ganglia to 1.2 microM ABgT does not prevent the effects of KBgT, indicating that the blockade occurs at a site distinct from that recognized by ABgT. Binding of [125I]KBgT to ciliary ganglia reveals two binding sites: one which has previously been characterized by [125I]ABgT and one which is not identified by [125I]ABgT. Both of these [125I]KBgT binding sites are blocked following pre-treatment of ganglia with the irreversible nicotinic affinity agent bromoacetylcholine. A two-site model is proposed to account for these observations. One site (the ABgT binding site) is seen by both ABgT and KBgT, and has as yet no physiological function associated with it. The second site is recognized only by the physiologically active KBgT, and may represent binding of the toxin to the physiologically detected nicotinic receptor.

Short- and long-term influences of neonatal sex steroids on alpha-bungarotoxin binding capacity in the mouse amygdala

Short- and long-term influences of various neonatal hormonal manipulations were assessed in the mouse amygdala with respect to alpha-bungarotoxin binding capacity, a possible parameter for cholinergic receptor integrity and function. To estimate the short-term effects, [125I]alpha-bungarotoxin binding to the tissue homogenate obtained from the posterior corticomedial amygdala was determined by a filtration assay using mice killed at 14 days post partum. The amygdaloid tissue from the normal male had a greater binding capacity for [125I]alpha-bungarotoxin than that from the normal female. However, castration of the male on the day of birth decreased the binding down to the female's level. A treatment of the female with either 250 micrograms testosterone propionate or 10 micrograms estradiol benzoate on days 1, 3, 5 and 7 increased the binding up to the male's level, although similar neonatal administration of 250 micrograms 5 alpha-dihydrotestosterone was ineffective. The long-term effects of neonatal hormonal manipulations were examined with 77-day-old mice which had been gonadectomized for 49 days. A quantitative light-microscopic autoradiography for [125I]alpha-bungarotoxin binding showed that specific grain density over the nucleus amygdaloideus medialis posterior of the androgenized female exceeded that of the female without neonatal hormone treatment. These observations provide further evidence that neonatal sex steroids play a determinate role in the sexual differentiation of the brain by exerting an organizational influence on developing cholinergic binding sites in the amygdala.

Immunohistochemical localization of monoclonal antibodies to the nicotinic acetylcholine receptor in chick midbrain

We used the indirect immunofluorescence method to determine the crossreactivity of a library of 57 monoclonal antibodies (mAbs) against each of the subunits of the nicotinic acetylcholine receptor (nAcChoR) isolated from Torpedo and Electrophorus electric organs or from fetal calf and human muscle, with specific neural elements in the midbrain of the chick. Out of 17 mAbs that recognized motor end plates on chick muscle, 14 produced a similar pattern of labeling in the midbrain: the neuronal perikarya and dendrites in the lateral spiriform nucleus (SpL) were intensely labeled, and there was moderate labeling of fibers in certain of the deeper layers of the optic tectum, which disappeared after the SpL was destroyed electrolytically. Two lines of evidence suggest that the mAbs may be crossreacting with nAcChoRs in the midbrain. First, all of the mAbs that stained the SpL also stained neuromuscular junctions in skeletal muscle, whereas none of the 40 mAbs that failed to stain end plates crossreacted with the SpL; second, in vitro immunological studies and blocking experiments on tissue sections (in which unlabeled mAbs were used to block the staining of a directly fluorescein-treated mAb) indicated the presence of mAbs specific for unique antigenic determinants on all four of the subunits (alpha, beta, gamma, and delta) from Torpedo nAcChoR in chick midbrain and muscle. On the other hand, the distribution of mAb staining in the optic tectum does not closely parallel that of either acetylcholinesterase staining or of 125I-labeled alpha-bungarotoxin binding; no toxin binding has been observed autoradiographically in the SpL, but the nucleus does contain moderately dense acetylcholinesterase staining. Take together, our observations suggest that there may be a cholinergic input to the SpL and that the projection fibers from the SpL to the optic tectum (which are also stained with an antiserum to [Leu]enkephalin) may contain presynaptic nAcChoRs. It is clear, however, that the distribution of the putative nAcChoRs, alpha-bungarotoxin binding sites, and acetylcholinesterase staining in the avian midbrain are quite different, although they do overlap to some degree in the deeper layers of the optic tectum.

Extra-synaptic localization of alpha-bungarotoxin receptors in cultured chick ciliary ganglion neurons

Surface [125I]alpha-bungarotoxin receptors were localized on dissociated cultures of embryonic chick ciliary ganglion neurons by electron microscopic autoradiography. Grain density was 4-5-fold higher on cell body membrane versus neuritic process membrane, and there was no apparent concentration of grains at morphologically identifiable inter-neuronal synapses.

Interaction of histrionicotoxin with the putative nicotinic acetylcholine receptor of the chick visual system

The frog alkaloid histrionicotoxin inhibits neuromuscular transmission in a non-competitive fashion and is thought to bind to the ion channel region of the nicotinic acetylcholine receptor (nAChR) of skeletal muscle and fish electric organ. Here, the use of histrionicotoxin as a probe for the putative nAChR of the chick visual system was investigated. Histrionicotoxin inhibited the binding of [125I]alpha-bungarotoxin to synaptic membranes of optic lobe or of retina in a competitive manner (Ki = 6 +/- 3 microM). However, the number of displaceable membrane binding sites for the physiologically active derivative [3H]perhydrohistrionicotoxin was 20-100-fold higher than of [125I]alpha-bungarotoxin binding sites. Also, the binding of [3H]perhydrohistrionicotoxin to the membranes could be displaced by local anaesthetics and phencyclidine, but was insensitive to nicotinic-cholinergic ligands or to alpha-bungarotoxin. It is concluded that histrionicotoxins are not specific ligands for nAChR in the chick CNS.

Effects of ovariectomy on the binding of [125I]-alpha bungarotoxin (2.2 and 3.3) to the suprachiasmatic nucleus of the hypothalamus: an in vivo autoradiographic analysis

alpha-Bungarotoxin (alpha-BTX) has been used to label receptor binding sites on neural membranes. alpha-BTX fractions 2.2 and 3.3 were purified from Bungarus multicinctus by the method of Ravdin and Berg (1979) and we iodinated. There was no difference between these two fractions in their binding affinity or specificity of binding with hypothalamic synaptosomes. [125I] alpha-BTX 2.2S, 3.3 and commercially obtained [125I] alpha-BTX were injected into the third ventricle of ovariectomized female rats (n = 22), normally cycling rats (n = 12) or normal male rats (n = 4) and autoradiographic examination performed. Saline injected hypothalami (n = 4) or hypothalamus. Examination of serial sections from animals injected with each [125I] alpha-BTX showed that the supraoptic, periventricular, arcuate, premamillary and mamillary nuclei were consistently labeled. While the suprachiasmatic nucleus (SCN) in the intact females and males both showed high densities of alpha-BTX binding, the SCN in ovariectomized females showed little or no alpha-BTX binding. Thus, the labeling of the SCN in females without ovaries and ovarian hormones was markedly different from that of the intact males and females. Labeling patterns in castrate and intact animals may contribute to our understanding of gonadal steroid regulation of hypothalamic function.

Presence of an endogenous factor which inhibits binding of alpha-bungarotoxin 2.2 to its receptor

Cerebral cortical membranes and supernatant from rat were prepared by centrifugation of tissue homogenates at 45,000 g for 10 min. The supernatant fraction thus obtained was found to significantly inhibit alpha-bungarotoxin binding to the membrane preparation. After a 3 min incubation period, the supernatant inhibited toxin binding by approximately 65%, while the inhibition declined to about 40% after 30 min of incubation, presumably due to the slow reversibility of alpha-bungarotoxin binding. The choice of buffer was found to be an important determinant of the degree of inhibition observed, with 10 mM Tris pH 7.4 providing the most effective condition. This inhibition of toxin binding to cortical membranes by the 45,000 g supernatant was shown not to be due to adsorption of the radiolabeled compound to soluble or residual particulate material in the supernatant fraction. Specificity of the supernatant for the alpha-bungarotoxin site was demonstrated; a supernatant fraction could be prepared which inhibited alpha-bungarotoxin binding by 50% but had no effect on [3H]spiroperidol (DA2 and 5-HT2), [3H]prazosin (alpha 1-adrenergic, [3H]5-hydroxytryptamine (5-HT1) and [3H]quinuclidinylbenzilate (muscarinic cholinergic) binding. The inhibition of toxin binding also occurred in several other CNS regions including hippocampus, brainstem, spinal cord and cerebellum with an 80 to 90% inhibition of binding occurring in the latter two regions. In addition, the 45,000 g cortical supernatant completely prevented the binding of alpha-bungarotoxin to extrajunctional neuromuscular receptors and inhibited the binding to junctional receptors by 50%. Supernatants prepared from heart, liver and kidney or bovine serum albumin, at a concentration similar to the supernatant fraction, did not alter radiolabeled toxin binding to cortical membranes, while supernatant prepared from striated muscle tissue was effective. These results suggest there may be an endogenous ligand for the alpha-bungarotoxin 2.2 binding site in tissues which receive nicotinic cholinergic innervation.

Immunological cross-reactivity between the alpha-bungarotoxin-binding component from rat brain and nicotinic acetylcholine receptor

An alpha-bungarotoxin-binding protein was partially purified from rat brain and, when complexed with [125I] alpha-bungarotoxin, was shown to behave as a single radiolabelled protein that is distinct from the similarly complexed nAChR from Torpedo marmorata. The alpha-bungarotoxin-binding protein was used as antigen in radioimmunoassays for rabbit anti-(rat muscle nAChR) and rabbit anti-(Torpedo nAChR) antibodies, giving titres approximately 5% and 0.5%, respectively, of those obtained by using homologous antigen in the same assay.

Nicotinic acetylcholine receptor from chick optic lobe

An alpha-bungarotoxin-sensitive nicotinic cholinergic receptor from chick optic lobe has been completely purified. Its standard sedimentation coefficient is 9.1 S. The value near 12 S reported for the related component from other brain regions can be reproduced when the initial extraction is by Triton X-100 (rather than Lubrol PX), but other protein is then complexed with it. A single subunit of apparent molecular weight 54,000 is detected, and this subunit is specifically labeled by bromo-[3H]acetylcholine, but only after disulfide reduction. The same size subunit likewise is labeled in the protein (purified similarly) from the rest of the chick brain which can also bind alpha-bungarotoxin and nicotinic ligands. Immunological crossreactivity is demonstrated between both of these proteins with an antiserum to pure acetylcholine receptor from skeletal muscle. The acetylcholine receptor from chick optic lobe and the alpha-bungarotoxin-binding protein from the rest of the brain appear similar or identical by a series of criteria and are related to (but with differences from) peripheral acetylcholine receptors.

Cholinergic agonist-induced down regulation of neuronal alpha-bungarotoxin receptors

The ability of cholinergic ligands to regulate neuronal alpha-bungarotoxin receptor number was studied in dissociated monolayer cultures of embryonic chick ciliary ganglion neurons. Carbamylcholine and nicotine, but not D-tubocurarine, caused a loss of 25% of the surface [125I]alpha-bungarotoxin receptors within 1 h at 37 degrees C. This receptor loss occurred without change in affinity for [125I]alpha-bungarotoxin, was temperature-sensitive and was prevented by co-incubation with D-tubocurarine.

Analysis of alpha-bungarotoxin binding in the goldfish central nervous system

We report here the equilibrium, kinetic, and pharmacological analysis of alpha-125I-bungarotoxin (alpha-125I-Bgt) binding to a Triton X-100-solubilized goldfish brain synaptosomal fraction. In addition, a refined analysis of equilibrium binding to a particulate synaptosomal fraction is presented. Equilibrium binding from both particulate and soluble fractions revealed an apparent heterogeneity of binding sites. Kinetic analysis of the soluble receptor revealed linear association kinetics and nonlinear dissociation kinetics. The dissociation curve suggested the presence of at least two rate constants. Potential sources of the binding heterogeneity found in both the equilibrium binding and dissociation kinetics experiments are (1) multiple receptor species, (2) multiple ligand species, and (3) different, possibly interconvertible, states of a single receptor type. No evidence for the first two alternatives was found. Support for the third alternative was obtained by observing the effect of cholinergic ligands on alpha-125I-Bgt dissociation. Carbamylcholine and d-tubocurarine increased the apparent proportion of rapidly dissociating sites, suggesting that the two binding affinities can be interconverted and may arise from a single receptor type. Evidence concerning the identity of the alpha-Bgt binding protein as a nicotinic acetylcholine receptor is discussed.